RDIF and ChemRar agree to supply Avifavir to 17 countries
The Russian Direct Investment Fund (RDIF) and ChemRar Group will be supplying a Covid-19 drug, Avifavir, to 17 countries. Avifavir,…
24 Sep 2020
WIRED Health:Tech 2020: challenges facing Covid-19 vaccines
An unsurprising focus of WIRED Health:Tech 2020, which was held virtually on 22 September, was the ongoing Covid-19 pandemic. This novel coronavirus has affected everyone’s lives profoundly over the last…
23 Sep 2020
Sanofi and GSK sign Covid-19 vaccine supply deal with Canada
Sanofi and GlaxoSmithKline (GSK) have signed a deal with the Government of Canada to supply up to 72 million doses of adjuvanted Covid-19 vaccine candidate from next year. The vaccine…
23 Sep 2020
Fujifilm to seek approval for Avigan in Covid-19 after positive data
Japan's Fujifilm Toyama Chemical plans to seek approval for its anti-viral drug Avigan (favipiravir) to treat patients with Covid-19, after obtaining positive results in Phase III clinical trial. Avigan secured…
23 Sep 2020
Q&A with INmune’s Dr RJ Tesi: is TNF the key to treating the Covid-19 cytokine storm?
To date, just under 961,000 people have tragically died from Covid-19, according to John Hopkins University’s Covid-19 dashboard. Covid-19 deaths have been found to be mainly linked to an over-reaction…
21 Sep 2020
Sanofi and GSK agree to supply Covid-19 vaccine doses to EU
Sanofi and GlaxoSmithKline (GSK) have signed an advanced purchase agreement with the European Commission (EC) to supply up to 300 million doses of their potential Covid-19 vaccine, following regulatory approval.…
21 Sep 2020
Repurposing a COPD drug for Covid-19 with Verona Pharma
UK-based Verona Pharma is developing a novel drug for chronic obstructive pulmonary disease (COPD) called ensifentrine. As a novel dual inhibitor of PD3 and PD4 enzymes, ensifentrine acts as both…